Randomized, Double-blind Placebo-controlled Phase I Study to Assess Safety, Tolerance Pharmacokinetics of Multiple-dose Kukoamine B Mesilate in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 06 May 2017
At a glance
- Drugs Kukoamine B (Primary)
- Indications Sepsis
- Focus Adverse reactions
- Sponsors Tianjin Chase Sun Pharmaceutical
- 02 May 2017 Status changed from recruiting to completed.
- 30 May 2016 Status changed from not yet recruiting to recruiting.
- 26 Feb 2016 New trial record